The rational designed antagonist derived from the complex structure of interleukin-6 and its receptor affectively blocking interleukin-6 might be a promising treatment in multiple myeloma.

Source:http://linkedlifedata.com/resource/pubmed/id/16626851

Download in:

View as

General Info

PMID
16626851